Acute endophthalmitis following intravitreal triamcinolone acetonide injection [3]

American Journal of Ophthalmology

Volumn 137, Issue 6, 2004, Pages 1158-1159

  Canakis, Christina ^a   Livir Rallatos, Charalampos ^a   Zafirakis, Panayiotis ^a   Livir Rallatos, Gerasimos ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; TRIAMCINOLONE ACETONIDE;

ACUTE DISEASE; APHAKIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; ENDOPHTHALMITIS; HUMAN; INCIDENCE; INFECTION RISK; LETTER; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA MACULA CYSTOID EDEMA; RISK FACTOR; TREATMENT OUTCOME; UVEITIS;

EID: 2942585107     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.01.029     Document Type: Letter

References (3)

1. Conway M.D., Canakis C., Livir-Rallatos C., Peyman G.A. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 29:2003;27-33
2. Jonas J.B., Kreissig I., Hugger P., Sauder G., Panda-Jonas S., Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol. 87:2003;462-468
3. Jonas J.B., Kreissig I., Degenring R.F. Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide. Klin Monatsbl Augenheilkd. 220:2003;384-390